Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
LENZ Therapeutics, Inc. (LENZ) had Weighted-Average Shares Outstanding (Diluted) of 28.54M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$12.50M |
|
$-16.70M |
|
-- |
|
$12.50M |
|
$31.39M |
|
$-18.89M |
|
$2.19M |
|
$-16.70M |
|
$-16.70M |
|
$-16.70M |
|
$-16.70M |
|
$-16.70M |
|
$-16.70M |
|
$-18.89M |
|
$-16.74M |
|
28.54M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
28.54M |
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$207.00M |
|
$1.26M |
|
$3.71M |
|
$210.70M |
|
$16.32M |
|
-- |
|
$0.46M |
|
$16.78M |
|
$193.93M |
|
$193.93M |
|
$193.93M |
|
28.59M |
|
| Cash Flow Statement Financials | |
$-36.15M |
|
$14.14M |
|
$27.13M |
|
$20.27M |
|
$25.40M |
|
$5.13M |
|
$8.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-151.10% |
|
-151.10% |
|
-- |
|
-133.60% |
|
-133.60% |
|
$-36.93M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-8.61% |
|
-8.61% |
|
-7.93% |
|
-8.61% |
|
$6.78 |
|
$-1.29 |
|
$-1.27 |
|